Enfuvirtide Patent Expiration
Enfuvirtide is Used for managing HIV infection. It was first introduced by Hoffmann La Roche Inc
Enfuvirtide Patents
Given below is the list of patents protecting Enfuvirtide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Fuzeon | US6475491 | Treatment of HIV and other viral infections using combinatorial therapy |
Jun 07, 2015
(Expired) | Roche |
| Fuzeon | US6133418 | Synthetic peptide inhibitors of HIV transmission |
Nov 17, 2014
(Expired) | Roche |
| Fuzeon | US5464933 | Synthetic peptide inhibitors of HIV transmission |
Jun 07, 2013
(Expired) | Roche |
Enfuvirtide's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List